Generic player Mylan announced ( announced in a press release Here) the settlement of all patent litigation relating to the generic version of Schering- Plough's Desloratadine 5 mg Tablets (Clarinex).
Earlier, innovator had sued various generic players like Zydus, Sandoz, Mylan, Orchid, Perrigo, Glenmark, GeoPharma, Lupin, Ranbaxy, Sun, Watson, Dr. Reddy's who filed ANDA to market this product. Importantly, Innovator has patents listed in orange Book with expiries in 2020.
Earlier, innovator had sued various generic players like Zydus, Sandoz, Mylan, Orchid, Perrigo, Glenmark, GeoPharma, Lupin, Ranbaxy, Sun, Watson, Dr. Reddy's who filed ANDA to market this product. Importantly, Innovator has patents listed in orange Book with expiries in 2020.
Apart from Mylan, innovator had settled with Geopharm, Perrigo, Watson Pharma and Ranbaxy, Dr. Reddy, Lupin.
Possibly, all generic players are in licensing agreement with Innovator and would launch generic around July, 2012.
No comments:
Post a Comment